Developing a therapy to extend the efficacy of levodopa for Parkinson's disease.
Industry: Health Care
First Day Return: +38.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/14/2015 |
Offer Price | $14.89 |
Price Range $14.82 - $14.82 | |
Offer Shares (mm) | 3.8 |
Deal Size ($mm) | $56 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/10/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $56 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Turku, Finland |
Founded | 1998 |
Employees at IPO | 40 |
Website www.biotie.com |